"Echo Therapeutics, Inc. (OTCBB: ECTE) moved higher on Wednesday, gaining 1.45% or $.02 on 42,950 shares traded. While the recent trading activity has been intriguing, the future potential of the company is what really has us hooked. As mentioned in yesterday’s analyst report, Echo is positioned to dominate the global diabetic monitoring marketplace with its revolutionary needle-free system. The company also has a multitude of additional opportunities at its fingertips."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.